NeoStem Inc - NBS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

NeoStem Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
NBS	American	8731	http://www.neostem.com	0.5775 +0.0125
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for NeoStem Inc A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013 - May 20th, 2013 9:38 am NEOSTEM, INC. Financials - May 17th, 2013 11:04 am 4 Healthcare Stock Stories For Thursday Investing Wellness - May 16th, 2013 4:13 pm NeoStem announces geographic expansion of IP coverage of AMR-001 - May 16th, 2013 5:38 am NeoStem Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001 - May 16th, 2013 5:30 am 3 Biotech Stocks With Potential - May 14th, 2013 6:16 am NeoStem to Present at Multiple Conferences in May - May 14th, 2013 5:30 am NeoStem's Subsidiary, Progenitor Cell Therapy, to Provide Autologous and Allogeneic Cellular Therapy Services to MedStar Georgetown University Hospital - May 13th, 2013 5:30 am 5 Stocks To Watch For Gains Next Week - May 11th, 2013 8:52 pm NeoStem Clarification: No New Securities Being Issued - May 9th, 2013 5:54 pm NeoStem CEO's Letter to Shareholders - May 9th, 2013 2:06 pm NEOSTEM, INC. Files SEC form 10-Q, Quarterly Report - May 9th, 2013 7:05 am Interviewing Dr. Losordo: The Promising Development Of CD34 Cells - May 8th, 2013 1:21 am NeoStem Announces Closing of Public Offering of Common Stock - May 3rd, 2013 7:55 am NeoStem Announces Closing of Public Offering of Common Stock - May 3rd, 2013 6:50 am Stem Cells: Invest At Your Own Peril - May 1st, 2013 3:33 am NEOSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits - Apr 30th, 2013 11:12 pm NeoStem Announces Partial Exercise of Underwriters’ Over-Allotment Option - Apr 30th, 2013 4:55 pm NeoStem Announces Partial Exercise of Underwriters' Over-Allotment Option - Apr 30th, 2013 4:28 pm NeoStem Announces Proposed Public Offering of Common Stock - Apr 30th, 2013 10:10 am View All Current Headlines >>